BD Launches "Power in Prevention" Program to Help Minimize Risk of Infections during Surgical Process at 2017 AORN Annual Conference

Visit booth #1115 to learn about the BD program focused on improving education, process and efficiency to impact patient safety

BOSTON, April 3, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its quality improvement program, BD "Power in Prevention" at the Association of periOperative Registered Nurses (AORN) annual conference being held in Boston from April 1 – 5.

The BD Power in Prevention program leverages critical insights from the company's Focus on Quality Care program, which since its inauguration in 2012, has conducted more than 20,000 observations at more than 800 facilities in the field of infection prevention. The newly established BD Power in Prevention program builds on BD's heritage of minimizing the risks of infection to help standardize processes and promote high-quality outcomes for optimal patient care. Led by a team of clinicians and product experts, this unique program uses a comprehensive quantitative process to identify potential risks for infections and provides evidence-based infection control strategies for specific areas of quality improvement in skin preparation, hair removal, surgical instrument care and handling and hand-hygiene. Facilities participating in the BD Power in Prevention program recognized tangible results includingi a 50 percent increase in compliance to manufacturers' directions for skin prep as well as a 20 percent reduction in practice variability.

"We are grateful for the BD Power in Prevention program because it gave us the necessary tools and resources to have a formal quality improvement initiative at our clinic," said Cheryl Bennett, vascular OR project lead, Carilion Clinic. "We have been involved in many of these types of programs before but this is one of the few where we can see a difference in our nurses – they feel empowered to make a difference."

The BD commitment to advancing health and quality care initiatives will be highlighted in two onsite opportunities for conference attendees.

  • BD will sponsor and participate in the Executive Leadership Summit on Monday, April 3, from 7 to 8:15 a.m. Dr. Allan J. Morrison, Jr., a well-known infection preventionist, will present "McDreamy vs. Reality," unpacking the importance of standardization within the surgical suite and the many risks for potential infections. Breakfast will be provided to registered attendees.
  • AORN attendees will have the opportunity for continuing education (CE) facilitated by Pfiedler Enterprises in the BD booth #1115. Pfiedler Enterprises develops and implements continuing medical, nursing and adult education across the world. Four sessions of "Advancing Quality Improvement Throughout the Surgical Suite" will take place between 10 a.m. and 4 p.m. EST on Monday, April 3, and three sessions will occur between 9 a.m. and 2 p.m. EST Tuesday, April 4. Each course will last 30 minutes.

About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit

i Results from facilities reevaluated at 6 months


Matt Coppola                

Monique N. Dolecki

BD Public Relations      

BD Investor Relations




To view the original version on PR Newswire, visit:

SOURCE BD (Becton, Dickinson and Company)